Vivici’s €12.5M backing pushes animal-free dairy closer to scale
Vivici secured €12.5M from the European Innovation Council to scale animal-free dairy proteins, reinforcing the B2B infrastructure angle in alternative protein.
Alternative protein is hard because the science has to become commercially useful. Vivici’s new backing points to a more infrastructure-led version of foodtech: ingredients first, consumer brands later.
What happened
Dutch ingredients startup Vivici secured €12.5M from the European Innovation Council Accelerator Programme.
The company uses precision fermentation to produce animal-free dairy proteins. Its focus is on scaling its Vivitein ingredient portfolio for food and nutrition companies, rather than building only a consumer-facing food brand.
Why it matters
This is a stronger venture angle than many alternative-protein stories because Vivici is positioned as a B2B ingredient platform.
Instead of convincing consumers to switch to one branded product, the company can supply functional dairy proteins into multiple downstream categories. That could include nutrition products, food formulations and future dairy alternatives.
The bigger picture
Foodtech is moving from hype-heavy consumer launches toward harder infrastructure questions: cost, scale, functionality and supply reliability.
Vivici’s funding shows that animal-free dairy still has investor and institutional support when the model is focused on ingredients infrastructure and commercial scale, not just novelty.